May 2, 2026, 3:35 PM EDT. Labcorp Holdings (LH) stock has fallen 0.4% recently, with a 5.8% decline over three months despite a modest 4.4% total return over the past year. Analysts see the shares as undervalued by about 17.5%, with a fair value near $310 compared to the last close at $255.84. Advances in AI-driven operational efficiencies and the Invitae acquisition support margin growth, but challenges from tariffs, regulatory changes like PAMA, and pricing pressures in diagnostics create risks. Investors face a delicate balance between potential gains and headwinds. Labcorp's mixed recent momentum contrasts with strong longer-term returns, prompting calls for timely review of fundamentals and alternative healthcare investments.